UPC_CFI_424/2023 ACT_586899/2023 CC_13509/2024 and CC_13898/2024

ORDER

of the Court of First Instance of the Unified Patent Court Local Division The Hague issued on 29 January 2025

Dexcom Inc.

(Defendant) - of claim

6340

Sequence

Drive - CA

92121-4356 -

San Diego -

US

Statement

served on

30/11/2023

Dexcom

International

Limited

(Defendant) - 20/12/2023

1 Lampousas

Street - 1095

• Nicosia - CY

Statement

of claim

served on

R EFERENCE C ODE

ECLI: Not provided

CLAIMANT/S

1) Abbott Diabetes Care Inc.

(Claimant) - 1360 South Loop Road - CA 94502

Represented by Eelco

Bergsma

• Alameda - US

DEFENDANT/S

1. Dexcom Inc.

(Defendant) - 6340 Sequence Drive - CA

92121-4356 - San Diego - US

Represented by Tjibbe Douma

2) Dexcom International Limited

(Defendant) - 1 Lampousas Street - 1095 - Nicosia - CY

Represented by Tjibbe Douma

PATENT AT ISSUE

DECIDING JUDGES

Presiding judge Judge-rapporteur

Edger Brinkman Edger Brinkman

L ANGUAGE OF P ROCEEDINGS

: English

S UBJECT MATTER OF THE -P ROCEEDINGS

counter claims for revocation

G ROUNDS

All parties to the proceedings requested withdrawal of their respective claims (above-mentioned infringement claim and counter claims for revocation). By order of today, the full panel of the court has allowed these withdrawals.

Dexcom's request for reimbursement of 20% of the court fees can be allowed as well (R. 370.9). In as far as necessary, the value of the actions is set at 4 million euro.

O RDER

The court:

• -orders the claimant in the counter claims to be reimbursed 20% of the court fees paid, and thus an amount of EUR 4.000.

• -sets the value of the cases at EUR 4.000.000.

O RDER DETAILS

Order no. ORD_68862/2024 in ACTION NUMBER: ACT_586899/2023, CC_13509/2024 and CC_13898/2024

UPC number: UPC_CFI_424/2023

Action type:

Counter Claims for revocation

Related proceeding no. App_68474/2024, App_68465/2024 and App_68468/2024